Stamford, CT -- (SBWIRE) -- 01/21/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT), FUSE SCIENCE, INC (OTCMKTS:DROP), Affymax, Inc. (OTCMKTS:AFFY), Lot78 Inc (OTCMKTS:LOTE)
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) opened the session at $2.85, trading in a range of $2.71 - $2.93. The stock showed a positive performance of +10.15% in the last trading session from its previous close of $2.66 and closed at $2.93. The stock traded on a volume of 2.13 million shares and the average volume of the stock remained 2.12 million shares. Provectus Pharmaceuticals, Inc. is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications. The Company develops and focuses to license or market and sells its two prescription drug candidates, PV-10 and PH-10. The Company has transferred all its intellectual property related to over the counter (OTC) products and non-core technologies to its subsidiaries and designated, such subsidiaries as non-core to its primary business of developing its oncology and dermatology prescription drug candidates.
For How Long PVCT will Fight for Profitability? Read This Trend Analysis report
FUSE SCIENCE, INC (OTCMKTS:DROP) traded 4.37 million shares in the last business day while the average volume of the stock remained 3.97 million shares. The stock showed a positive movement of +9.20% to end at $0.0190. The 52 week range of the stock remained $0.01 - $0.28. Fuse Science, Inc., a consumer products company, develops alternative delivery systems with applications in the sports nutrition and medical fields. Its delivery systems include sublingual and transdermal delivery technologies that enable energy, medicines, vitamins, and minerals to bypass the gastrointestinal tract and enter the blood stream directly. The company offers EnerJel to address muscle fatigue and soreness, before, during, and after physical activity.
For How Long DROP’s Gloss will Attract Investors? Find out via this report
Affymax, Inc. (OTCMKTS:AFFY) reported 1.15 million shares were exchanged during the last trade, while the average volume is about 375,654 shares. The stock escalated +8.91% and finished the day at $1.00. The beta of the stock is recorded at 1.35. Affymax, Inc. is a biopharmaceutical company engaged in developing drugs to improve the treatment of serious and often life-threatening conditions. Its product candidate, peginesatide, is for the treatment of anemia in chronic kidney disease patients on dialysis. Peginesatide is a synthetic peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells.
For How Long AFFY’s Gloss will Attract Investors? Find out via this report
Lot78 Inc (OTCMKTS:LOTE) shares rose, +8.79 percent from its previous close of $0.091 to close at $0.0990. Traded with volume of 1.67 million shares in the prior session and the average volume of the stock remained 497,073 shares. Lot78, Inc. designs, markets, distribute, and sell apparel under the brand name Lot78 to fashion-conscious consumers on four continents, including North America, Europe, Asia, and South America. The Company seeks to be a trend setting in the design, marketing, distribution and sale of luxury street apparel. The Company’s collection is a full men’s and women’s contemporary ready to wear line, which includes leather jackets, t-shirts, sweats, knitwear, chinos, and wool coats. The Company operates in three segments: Wholesale, Consumer Direct and Core Services.
Why Should Investors Buy LOTE After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)